WAVE Life Sciences – IPO

Boston – December 7, 2015 – Cooley advised the underwriters on WAVE Life Sciences' $102 million initial public offering. WAVE Life Sciences is a preclinical biopharmaceutical company with an innovative and proprietary synthetic chemistry drug development platform that it is using to design, develop and commercialize a broad pipeline of first-in-class or best-in-class nucleic acid therapeutic candidates. The company now trades on the NASDAQ Global Market under the symbol "WVE."

Jefferies and Leerink Partners acted as joint book-running managers for the offering. JMP Securities and SunTrust Robinson Humphrey acted as co-managers for the offering.

The Cooley corporate and securities team advising the underwriters included Frank Rahmani, Nicole Brookshire, John McKenna, Alison Haggerty, David Bartholomew, Maggie Siegel and Layne Jacobs.

Critical support for the offering was provided by Natasha Leskovsek, Phil Mitchell and Leah Roffman (health care and life sciences regulatory); Ivor Elrifi, Heidi Erlacher and Lian Ouyang (IP); Joshua Friedman and Jessica Mols (compensation and benefits); and Jeremy Naylor and Todd Gluth (tax).

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 850 lawyers across 12 offices in the United States, China and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may have been generated with the assistance of artificial intelligence (AI) in accordance with our AI Principles, may be considered Attorney Advertising and is subject to our legal notices.